Development and validation of a composite disease activity score for juvenile idiopathic arthritis

Arthritis Care and Research

Volumn 61, Issue 5, 2009, Pages 658-666

  Consolaro, Alessandro ^a   Ruperto, Nicolino ^b   Bazso, Anna ^b   Pistorio, Angela ^b   Magni Manzoni, Silvia ^c   Filocamo, Giovanni ^b   Malattia, Clara ^b   Viola, Stefania ^b   Martini, Alberto ^d   Ravelli, Angelo ^a  

^a UNIVERSITY OF VERONA   (Italy)

^b G GASLINI INSTITUTE   (Italy)

^c C MONDINO NATIONAL NEUROLOGICAL INSTITUTE   (Italy)

^d UNIVERSITY OF GENOA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

MELOXICAM; METHOTREXATE; NAPROXEN;

ARTICLE; CONSTRUCT VALIDITY; DISCRIMINANT VALIDITY; DISEASE ACTIVITY; DISEASE COURSE; ERYTHROCYTE SEDIMENTATION RATE; FUNCTIONAL ASSESSMENT; HUMAN; JOINT SWELLING; JUVENILE RHEUMATOID ARTHRITIS; MAJOR CLINICAL STUDY; PAIN ASSESSMENT; QUESTIONNAIRE; SCORING SYSTEM; VALIDATION STUDY; VISUAL ANALOG SCALE;

ADOLESCENT; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ANTIRHEUMATIC AGENTS; ARTHRITIS, JUVENILE RHEUMATOID; BLOOD SEDIMENTATION; CHILD; CHILD, PRESCHOOL; CROSS-SECTIONAL STUDIES; DISABILITY EVALUATION; HUMANS; JOINTS; METHOTREXATE; NAPROXEN; OUTCOME ASSESSMENT (HEALTH CARE); PROGNOSIS; SEVERITY OF ILLNESS INDEX; THIAZINES; THIAZOLES; TREATMENT OUTCOME;

EID: 66249138135     PISSN: 21514658     EISSN: None     Source Type: Journal    
DOI: 10.1002/art.24516     Document Type: Article

References (29)

1. Ravelli A, Martini A. Juvenile idiopathic arthritis. Lancet 2007;369:767-78.
2. Giannini EH, Ruperto N, Ravelli A, Lovell DJ, Felson DT, Martini A. Preliminary definition of improvement in juvenile arthritis. Arthritis Rheum 1997;40:1202-9.
3. Van der Heijde DM, van 't Hof M, van Riel PL, Theunisse LA, Lubberts EW, van Leeuwen MA, et al. Judging disease activity in clinical practice in rheumatoid arthritis: first step in the development of a disease activity score. Ann Rheum Dis 1990; 49:916-20.
4. Prevoo ML, van 't Hof MA, Kuper HH, van Leeuwen MA, van de Putte LB, van Riel PL. Modified disease activity scores thatinclude twenty-eight-joint counts: development and validation in a prospective longitudinal study of patients with rheumatoid arthritis. Arthritis Rheum 1995;38:44-8.
5. Smolen JS, Breedveld FC, Schiff MH, Kalden JR, Emery P, Eberl G, et al. A simplified disease activity index for rheumatoid arthritis for use in clinical practice. Rheumatology (Oxford) 2003;42:244-57.
6. Aletaha D, Nell VP, Stamm T, Uffmann M, Pflugbeil S, Machold K, et al. Acute-phase reactants add little to composite disease activity indices for rheumatoid arthritis: validation of a clinical activity score. Arthritis Res Ther 2005;7:R796-806.
7. Aletaha D, Smolen J. The Simplified Disease Activity Index (SDAI) and the Clinical Disease Activity Index (CDAI): a review of their usefulness and validity in rheumatoid arthritis. Clin Exp Rheumatol 2005;23:S100-8.
8. Palmisani E, Solari N, Magni-Manzoni S, Pistorio A, Lab E, Panigada S, et al. Correlation between juvenile idiopathic arthritis activity and damage measures in early, advanced, and longstanding disease. Arthritis Rheum 2006;55:843-9.
9. Ruperto N, Ravelli A, Falcini F, Lepore L, Buoncompagni A, Gerloni V, et al, and the Italian Pediatric Rheumatology Study Group. Responsiveness of outcome measures in juvenile chronic arthritis. Rheumatology (Oxford) 1999;38:176-80.
10. Ruperto N, Ravelli A, Migliavacca D, Viola S, Pistorio A, Duarte C, et al. Responsiveness of clinical measures in children with oligoarticular juvenile chronic arthritis. J Rheumatol 1999;6:1827-30.
11. Moretti C, Viola S, Pistorio A, Magni-Manzoni S, Ruperto N, Martini A, et al. Relative responsiveness of condition specific and generic health status measures in juvenile idiopathic arthritis. Ann Rheum Dis 2005;64:257-61.
12. Brunner HI, Klein-Gitelman MS, Miller MJ, Barron A, Baldwin N, Trombley M, et al. Minimal clinically important differences of the Childhood Health Assessment Questionnaire. J Rheumatol 2005;32:150-61.
13. Ruperto N, Giannini EH. Redundancy of conventional articular response variables used in juvenile chronic arthritis clinical trials. Ann Rheum Dis 1996;55:73-5.
14. Ravelli A, Viola S, Ruperto N, Corsi B, Ballardini G, Martini A. Correlation between conventional disease activity measures in juvenile chronic arthritis. Ann Rheum Dis 1997;56: 197-200.
15. Bazso A, Consolaro A, Ruperto N, Viola S, Magni-Manzoni S, Malattia C, et al. Development and testing of reduced joint counts in juvenile idiopathic arthritis. J Rheumatol 2009;36: 183-90.
16. Petty RE, Southwood TR, Manners P, Baum J, Glass DN, Goldenberg J, et al. International League of Associations for Rheumatology classification of juvenile idiopathic arthritis: second revision, Edmonton, 2001. J Rheumatol 2004;31: 390-2.
17. Oliveira S, Ravelli A, Pistorio A, Castell E, Malattia C, Prieur AM, et al, for the Pediatric Rheumatology International Trials Organization. Proxy-reported health-related quality of life of patients with juvenile idiopathic arthritis: the Pediatric Rheu- matology International Trials Organization multinational quality of life cohort study. Arthritis Rheum 2007;57:35-43.
18. Ruperto N, Murray KJ, Gerloni V, Wulffraat N, de Oliveira SK, Falcini F, et al. A randomized trial of parenteral methotrexate comparing an intermediate dose with a higher dose in children with juvenile idiopathic arthritis who failed to respond to standard doses of methotrexate. Arthritis Rheum 2004;50: 2191-201.
19. Ruperto N, Nikishina I, Pachanov ED, Shachbazian Y, Prieur AM, Mouy R, et al. A randomized, double-blind clinical trial of two doses of meloxicam compared with naproxen in children with juvenile idiopathic arthritis: short- and long-term efficacy and safety results. Arthritis Rheum 2005;52:563-72.
20. Singh G, Athreya BH, Fries JF, Goldsmith DP. Measurement of health status in children with juvenile rheumatoid arthritis. Arthritis Rheum 1994;37:1761-9.
21. Ravelli A, Ioseliani M, Norambuena X, Sato J, Pistorio A, Rossi F, et al. Adapted versions of the Sharp/van der Heijde score are reliable and valid for assessment of radiographic progression in juvenile idiopathic arthritis. Arthritis Rheum 2007;56:3087-95.
22. Franzblau A. Correlation coefficients. In: Hartcouts BW, editor. A primer of statistics for non-statisticians. New York: Harcourt Brace; 1958.
23. Liang MH, Larson MG, Cullen KE, Schwartz JA. Comparative measurement efficiency and sensitivity of five health status instruments for arthritis research. Arthritis Rheum 1985;28: 542-7.
24. Cohen J. Statistical power analysis for the behavioural sciences. New York: Academic; 1977.
25. Garcia-Munitis P, Bandeira M, Pistorio A, Magni-Manzoni S, Ruperto N, Schivo A, et al. Level of agreement between children, parents, and physicians in rating pain intensity in juvenile idiopathic arthritis. Arthritis Rheum 2006;55:177-83.
26. Brunner HI, Klein-Gitelman MS, Miller MJ, Trombley M, Baldwin N, Kress A, et al. Health of children with chronic arthritis: relationship of different measures and the quality of parent proxy reporting. Arthritis Rheum 2004;51:763-73.
27. Singh G, Athreya B, Fries JF, Goldsmith DP. Measurement of health status in children with juvenile rheumatoid arthritis. Arthritis Rheum 1994;37:1761-9.
28. Landgraf JM, Abetz L, Ware JE. The CHQ user's manual. Boston (MA): Health Institute; 1996.
29. Ramanan AV, Schneider R, Batthish M, Achonu C, Ota S, McLimont M, et al. Developing a disease activity tool for systemic-onset juvenile idiopathic arthritis by international consensus using the Delphi approach. Rheumatology (Oxford) 2005;44:1574-8.